Antonios Douros
University of Ottawa(CA)McGill University Health Centre(CA)Berlin Institute of Health at Charité - Universitätsmedizin Berlin(DE)Ottawa Public Health(CA)McGill University(CA)Charité - Universitätsmedizin Berlin(DE)Charité - Universitätsmedizin Berlin(DE)
Publications by Year
Research Areas
Diabetes Treatment and Management, Blood Pressure and Hypertension Studies, Atrial Fibrillation Management and Outcomes, Diabetes Management and Research, Pharmacovigilance and Adverse Drug Reactions
Most-Cited Works
- → Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis(2020)170 cited
- → Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study(2018)126 cited
- → Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study(2020)120 cited
- → Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study(2018)119 cited
- → Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events(2017)92 cited
- → Drug–drug interactions and safety of linezolid, tedizolid, and other oxazolidinones(2015)80 cited